Attached files

file filename
10-K - OBAGI MEDICAL PRODUCTS 10K - Obagi Medical Products, Inc.obagi200910k.htm
EX-31.2 - SECTION 302 CERIFICATION, PRESTON ROMM - Obagi Medical Products, Inc.exhibit312.htm
EX-32.1 - SECTION 906 CERTIFICATION, STEVE CARLSON - Obagi Medical Products, Inc.exhibit321.htm
EX-23.1 - CONSENT LETTER - Obagi Medical Products, Inc.exhibit231.htm
EX-10.34 - 2009 INCENTIVE PLAN - Obagi Medical Products, Inc.exhibit1034.htm
EX-10.36 - STEVE CARLSON AGREEMENT 4TH AMENDMENT - Obagi Medical Products, Inc.exhibit1036.htm
EX-10.35 - DDN 3PL - Obagi Medical Products, Inc.exhibit1035.htm
EX-10.27 - STEVE CARLSON AGREEMENT 3RD AMENDMENT - Obagi Medical Products, Inc.exhibit1027.htm
EX-10.11 - STEVE CARLSON AGREEMENT 1ST AMENDMENT - Obagi Medical Products, Inc.stevecexhibit.htm
EX-31.1 - SECTION 302 CERIFICATION, STEVE CARLSON - Obagi Medical Products, Inc.exhibit311.htm

Exhibit 32.2
Obagi Medical Products, Inc.

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
        In connection with the Annual Report on Form 10-K of Obagi Medical Products, Inc. for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Preston S. Romm, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
  Company Name  
       
Date: March 12, 2010
By:
/s/ Preston S. Romm  
    Preston S. Romm  
    Chief Financial Officer  
     (Principal Financial Officer)